Cancer care is expensive, and like other chronic illnesses, is prone to waste both through overuse of low-value services and underuse of evidence-based approaches.1 The fee-for-service model has been cited as a major factor, creating perverse incentives to provide high-cost, low-value care without sufficiently monitoring quality.2 Alternative models have been proposed as a means to both control costs and improve quality in oncology, including accountable care organizations, bundled episode-based payment models, and patient-centered medical homes.
Basch E. Evaluating Alternative Payment Models in Oncology. JAMA. 2017;317(20):2123–2124. doi:https://doi.org/10.1001/jama.2017.3028
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: